Active efflux has an important role in the antimicrobial resistance of Campylobacter jejuni and Campylobacter coli. The effects of two putative efflux pump inhibitors (EPIs), phenylalaninearginine b-naphthylamide and 1-(1-naphthylmethyl)-piperazine, and the effects of inactivation of the cmeB, cmeF and cmeR genes on resistance to a broad range of antimicrobials were studied using the broth microdilution method. The antimicrobials tested in C. jejuni and C. coli were the biocides triclosan, benzalkonium chloride, chlorhexidine diacetate, cetylpyridinium chloride and trisodium phosphate, along with the anionic surfactant SDS and the antibiotics erythromycin and ciprofloxacin. Both EPIs partially reversed the resistance to all of these antimicrobials. Differences between these EPIs were seen for substrate preference and reductions in MIC. The MICs of the antimicrobials were reduced in the cmeB and cmeF mutants and increased in the cmeR mutant, with few exceptions. Both of these putative EPIs further decreased the MICs of the antimicrobials in these mutant strains. These data confirm that active efflux is an important mechanism in biocide resistance in C. jejuni and C. coli. At least one non-CmeABC efflux system or reduced uptake is responsible for resistance to biocides.
INTRODUCTION
Thermotolerant Campylobacter species, and especially Campylobacter jejuni and Campylobacter coli, are the most commonly reported bacterial causes of food-borne gastroenteritis in humans worldwide (Moore et al., 2006) . These bacteria are usually transmitted by contaminated food and drinking water. As well as their widespread occurrence, Campylobacter species have become increasingly resistant to antibiotics (Smole Možina et al., 2011) .
Various antimicrobial chemical agents that efficiently inactivate bacteria, known as biocides, are regularly used today to prevent bacterial contamination, especially in the food industry and in the home (Langsrud et al., 2004; Møretrø et al., 2006) . In comparison with antibiotic resistance, bacterial resistance to biocides has only been described more recently, and has been less studied overall. Despite this, there have been numerous reports of bacterial resistance to biocides such as triclosan, quaternary ammonium compounds, chlorhexidine and trisodium phosphate (TSP) (Copitch et al., 2010; Lear et al., 2006; Tattawasart et al., 2000; Yuk & Marshall, 2006) . Many studies have been carried out over the last decade to understand better the molecular mechanisms of bacterial resistance to antimicrobial agents. Drug-specific and multidrug resistance mechanisms have been reported. The mechanisms of antibiotic resistance are generally well known, and include target-site mutations and active efflux (Smole Možina et al., 2011) . In contrast to antibiotics, which are considered to have activity against only one major target site, biocides have a broad spectrum of activity and can act at several target sites in bacterial cells (Russell, 2002) .
Bacterial resistance to biocides can result from changes in the bacterial envelope permeability or enhanced bacterial biocide efflux (Poole, 2002) . Target-site mutations and biocide inactivation or degradation have also been reported, although these remain comparatively rare and specific to a few biocides (Schweizer, 2001; Webber et al., 2008) . A potential concern is the possibility that mechanisms that provide resistance to biocides might also provide cross-protection to the activities of antibiotics. Indeed, the possibility of a link between biocide and antibiotic resistances in bacteria has been reported (Copitch et al., 2010; Meyer & Cookson, 2010; Russell, 2002) . However, contrasting evidence suggests that this phenomenon has not caused a real problem in practice (Lear et al., 2006; Mavri et al., 2012) . bacterial cell, including antibiotics, dyes and biocides, and these can confer a multidrug resistance phenotype to many bacteria (Li & Nikaido, 2004) . In C. jejuni and C. coli, the presence of the major efflux system, known as the CmeABC efflux pump, has been demonstrated to contribute to resistance to a broad range of antimicrobials (Lin et al., 2002; Martinez & Lin, 2006) . This is regulated through the transcriptional repressor CmeR, which interacts directly with the cmeABC promoter and thus modulates the expression of cmeABC (Lin et al., 2005) . A second efflux system, CmeDEF, has been identified in Campylobacter, which is functionally distinct from CmeABC (Akiba et al., 2005) . These two multidrug efflux systems belong to the resistance-nodulation-cell division (RND) family of transporters. As the C. jejuni genome contains at least eight other non-RND efflux pumps, these might also be involved in the extrusion of toxic compounds and could also mediate multidrug resistance (Pumbwe et al., 2005) . Indeed, the CmeGH multidrug efflux transporter from the major facilitator family has been demonstrated recently to contribute to antibiotic resistance in C. jejuni (Jeon et al., 2011) .
The involvement of efflux mechanisms in intrinsic and acquired resistance of bacteria is mostly demonstrated by the use of efflux pump inhibitors (EPIs), such as phenylalanine-arginine b-naphthylamide (PAbN) and 1-(1-naphthylmethyl)-piperazine (NMP), which enhance antimicrobial accumulation inside the bacterial cell, thereby increasing bacterial susceptibility (Hannula & Hänninen, 2008; Martinez & Lin, 2006) . Such studies can additionally be confirmed using genetic approaches with mutants lacking functional genes that encode these efflux pump proteins (Pumbwe et al., 2005) .
The aim of the present study was to analyse the effects of two EPIs, PAbN and NMP, on the susceptibility of C. jejuni and C. coli to a broad range of biocides, triclosan, benzalkonium chloride (BC), cetylpyridinium chloride (CPC), chlorhexidine diacetate (CHA) and TSP, as well as to the anionic surfactant SDS, which is added to a wide range of cleaning agents to assist in cleaning. To investigate the contributions of the CmeABC and CmeDEF efflux pumps to biocide resistance, mutants of C. jejuni strain NCTC 11168 lacking the cmeB and cmeF genes, which encode innermembrane efflux transporters, as well as a cmeR mutant, were screened for susceptibility to the antimicrobials in the presence and absence of these EPIs. As biocide resistance might be responsible for the selection of antibiotic-resistant bacteria, and as efflux mechanisms can contribute to multidrug resistance, the involvement of active efflux in the resistance to the clinically important antibiotics erythromycin and ciprofloxacin was also examined.
METHODS
Bacterial strains and growth conditions. The C. jejuni and C. coli strains isolated from animals (poultry and pig), humans and environmental water that were used in this study are listed in Table  1 . The cultures were stored at 280 uC in brain-heart infusion broth (Biolife) with 20 % horse blood (Oxoid) and 20 % glycerol (Kemika) (Herman et al., 2003) . The isolates were cultivated at 42 uC under microaerophilic conditions (3 % O 2 , 10 % CO 2 and 87 % N 2 ) in gastight containers on Karmali or Columbia agar, supplemented with 5 % horse blood. The reference strain used was C. jejuni NCTC 11168.
Mutant strains. Purified DNA from cmeB (Lin et al., 2002) , cmeF (Akiba et al., 2005) and cmeR (Lin et al., 2005) mutants (obtained from Professor Qijing Zhang, Iowa State University, IA, USA) was used to transform C. jejuni NCTC 11168 using standard biphasic methods for natural transformation and construction of the cmeB, cmeF and cmeR mutants (Wang & Taylor, 1990) . Our transformants of cmeB, cmeF and cmeR were confirmed by PCR (A. Klančnik, unpublished results) using the specific primers cmeB BF1 (59-GCTGGATCCATAGGTCTTACAAAT-39) and cmeB CR (59-TTTT-TAAAGCTTTAAGGTAATTTTCTT-39) (Lin et al., 2002) ; cmeF FF1 (59-AAGTACAACTCTCATTGCTTGCAT-39) and cmeF FR1 (59-TGGCTATTGCCATAGGAGAA-39) (Akiba et al., 2005) ; and cmeR F (59-TAGAAAAGTATATTTGTATACCCT-39) and cmeR GSR4 (59-GAAATTTTTGGCTAATTATAT-39) (Lin et al., 2005) .
Antimicrobial susceptibility testing. Campylobacter species isolates were selected from different sources, primarily on the basis of different antimicrobial resistances, as determined previously in our laboratory (Mavri et al., 2012) . The MICs of triclosan (Merck), BC, CHA, CPC, TSP (all from Sigma-Aldrich), SDS (Invitrogen), erythromycin (Sigma-Aldrich) and ciprofloxacin (Fluka) were determined using a broth microdilution method with microtitre plates, as described previously (Kurinčič et al., 2007) , in the absence and presence of PAbN (Sigma-Aldrich) and NMP (Chess). For this purpose, Mueller-Hinton broth was supplemented with PAbN or NMP to final concentrations of 10 and 60 mg ml 21 , respectively. Twofold serial dilutions of erythromycin, ciprofloxacin, triclosan and BC were used at concentrations of 0.016-512 mg ml 21 , CHA and CPC at concentrations of 0.016-2 mg ml 21 , TSP at concentrations of 0.5-64 mg ml 21 and SDS at concentrations of 0.125-1024 mg ml
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. The microtitre plates were incubated for 24 h at 42 uC under microaerophilic conditions. Ethanol (Merck) was used as the erythromycin and triclosan co-solvent, at concentrations previously shown to be non-inhibitory for bacterial cells. MICs were defined as the lowest concentration where no viable cells were present, and they were determined on the basis of fluorescent signals measured using a microplate reader (Tecan) after adding 20 ml CellTiter-Blue Reagent (Promega) to the culture medium, following the manufacturer's instructions. The assays were repeated twice in duplicate to confirm the reproducibility of the MIC data. Microdilution tests were also performed in preliminary independent experiments to determine the MICs of PAbN and NMP for all of the strains tested here. Concentrations of 10 mg PAbN ml 21 and 60 mg NMP ml 21 alone had no inhibitory effects on bacterial growth for any of the strains.
RESULTS AND DISCUSSION
In the present study, Campylobacter species strains with different resistance levels to triclosan, BC, TSP and erythromycin were included. The efficiencies of the EPIs PAbN and NMP were determined for each strain, in terms of the bacterial resistance to the five biocides triclosan, BC, CPC, CHA and TSP, and to SDS, erythromycin and ciprofloxacin. Additionally, to determine the contributions of the CmeABC and CmeDEF efflux pumps to biocide resistance, cmeB, cmeF and cmeR mutants of C. jejuni strain NCTC 11168 were screened for their sensitivity to all eight of these agents in the absence and presence of each EPI. The MICs from this full range of experiments are presented in Tables 1 and 2 . Table 3 presents the effects of PAbN and NMP in C. jejuni and C. coli. Resistance to triclosan was significantly reduced by both EPIs, with PAbN having greater effects (2-4000-fold triclosan MIC reductions) than NMP (2-8-fold triclosan MIC reductions). A significant difference between the PAbN effects in C. jejuni and C. coli was also seen: in C. jejuni, PAbN reduced the triclosan MICs from only 2-to 128-fold, whilst in C. coli, the reduction was from 4-to 256-fold, and in two C. coli strains (171 and 655) it was by much as 2000-and 4000-fold. PAbN and NMP decreased all of the triclosan MICs in all of the C. jejuni and C. coli strains, except for NMP in three out of 14 (21.4 %) of the C. jejuni strains. Both EPIs had greater effects in triclosanresistant than in triclosan-sensitive strains. In the high-level triclosan-resistant strains (MIC .32 mg ml
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), PAbN reduced the triclosan MICs by 16-4000-fold, and NMP by 4-8-fold. These data suggest that active efflux is an important mechanism in triclosan resistance in Campylobacter species, and this is in agreement with previous observations in Pseudomonas aeruginosa and Salmonella species, where mutations in the MexAB-OprM and AcrB-TolC efflux systems, respectively, greatly decreased triclosan resistance (Chuanchuen et al., 2001; Webber et al., 2008) .
Both EPIs significantly restored BC sensitivity in C. jejuni and C. coli (2-128-fold BC MIC reductions) with the same efficiency. PAbN decreased 12 out of 14 (85.7 %) and NMP ). However, no differences were seen between C. jejuni and C. coli for the effects on the BC MICs of either of these EPIs. These observations indicate that active efflux is involved in BC resistance in Campylobacter species, as has been demonstrated previously for Escherichia coli and Salmonella enterica (Langsrud et al., 2004) .
Similarly, both EPIs significantly reduced the MICs of erythromycin, where PAbN had greater effects (2-64-fold erythromycin MIC reductions) than NMP (2-16-fold erythromycin MIC reductions). A significant difference was observed in the effects of PAbN in C. jejuni (2-16-fold erythromycin MIC reductions) and C. coli (4-64-fold erythromycin MIC reductions). PAbN and NMP reduced all of the erythromycin MICs in all of the C. jejuni and C. coli strains, except for NMP in one out of 14 (7.1 %) of the C. jejuni strains. Both EPIs had large effects on erythromycin susceptibility in erythromycinresistant as well as in erythromycin-sensitive strains. PAbN had the greatest effect (64-fold erythromycin MIC reductions) in three of these C. coli strains, VC7114, VC110722 and VC110725, which showed unstable erythromycin resistance phenotypes, as determined in our previous investigations (Kurinčič et al., 2007; Mavri et al., 2012) . Our findings here suggest that erythromycin resistance that is not mediated by the A2075G mutation in the 23S rRNA gene might be mediated by active efflux, and would only be induced conditionally.
Of note, when comparing these data of PAbN effects on erythromycin resistance with those obtained in our previous study (Kurinčič et al., 2007) , the concentration of 10 mg PAbN ml 21 used in the present study reduced the erythromycin MICs in several cases by less than the 20 mg PAbN ml 21 used in our previous investigation (Kurinčič et al., 2007) . These data confirmed that PAbN reduces erythromycin resistance in a dose-dependent manner, which is in agreement with previously published data (Martinez & Lin, 2006) . Both EPIs significantly restored ciprofloxacin sensitivity in C. jejuni and C. coli (2-512-fold ciprofloxacin MIC reductions) with the same efficiency. However, these MIC reductions occurred in only a small proportion of tested strains. PAbN decreased five out of 14 (35.7 %) of the ciprofloxacin MICs in the C. jejuni strains and 12 out of 20 (40) *Number of strains (n)/number of tested C. jejuni or C. coli strains (N).
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(60 %) of the ciprofloxacin MICs in the C. coli strains. NMP decreased six out of 14 (42.9 %) of the ciprofloxacin MICs in the C. jejuni strains and eight out of 20 (40 %) of the ciprofloxacin MICs in the C. coli strains.
In contrast to triclosan, BC and erythromycin, smaller effects of both EPIs were seen for CPC, CHA and TSP susceptibilities. PAbN reduced the MICs of CPC and CHA by 2-16-fold, and reduced the CPC susceptibility in 33 out of 36 (91.7 %) of these strains: 12 out of 14 (85.7 %) for C. jejuni and 21 out of 22 (95.5 %) for C. coli. Slightly lower effects of PAbN were seen here in C. jejuni (2-8-fold CPC MIC reductions) than in C. coli (2-16-fold CPC MIC reductions). PAbN reduced the CHA susceptibility in a relatively low number of these strains (23 out of 36; 63.9 %), which was seen as only five out of 14 (35.7 %) for C. jejuni but 18 out of 22 (81.8 %) for C. coli. A lesser effect was observed in C. jejuni (2-fold CHA MIC reductions) than in C. coli (2-16-fold CHA MIC reductions). For TSP, PAbN reduced the MICs from 2-to 4-fold, although this was seen in a particularly low number of these strains (13 out of 36; 36.1 %): three out of 14 (21.4 %) for C. jejuni and ten out of 22 (45.5 %) for C. coli. Overall, PAbN had greater effects on CHA and CPC susceptibilities than NMP. NMP reduced the CPC MICs by 2-8-fold and the CHA MICs by 2-fold, with the same efficiencies in C. jejuni and C. coli. NMP reduced the CPC and CHA susceptibility in just over half (19 out of 36; 52.8 %) of these strains: seven out of 14 (50 %) for C. jejuni and 12 out of 22 (54.5 %) for C. coli. In contrast, PAbN had lower effects on TSP susceptibilities than NMP. Here, NMP reduced the TSP MICs from 2-to 8-fold, with these reductions in 30 out of 36 (83.3 %) of these strains: 13 out of 14 (92.9 %) for C. jejuni and 17 out of 22 (77.3 %) for C. coli.
Both EPIs significantly reduced the MICs of SDS, with the efficiency of PAbN (2-256-fold SDS MIC reductions) greater than that of NMP (2-16-fold SDS MIC reductions). PAbN had lower effects in C. jejuni (2-64-fold SDS MIC reductions) than in C. coli (8-256-fold SDS MIC reductions). PAbN and NMP reduced all of the SDS MICs in all of the C. jejuni and C. coli strains, except for PAbN in one out of 14 (7.1 %) of the C. jejuni strains, with the same efficiencies seen in C. jejuni and C. coli.
Effects of cmeB, cmeF and cmeR gene inactivation
The effects of cmeB, cmeF and cmeR gene inactivation on antimicrobial resistance in C. jejuni NCTC 11168 and the effects of PAbN and NMP addition are given in Table 2 . Inactivation of the cmeB gene had only small effects on resistance to the antimicrobials, with triclosan and CHA resistance reduced by twofold, and BC, ciprofloxacin and SDS resistance reduced by fourfold. Both EPIs additionally decreased the MICs of these antimicrobials in this cmeB mutant (by 2-32-fold). Inactivation of the cmeB gene had no effects on TSP susceptibility, with PAbN showing no additional effects here, whilst NMP reduced the TSP MIC by fourfold. Unexpectedly, the CPC MIC was increased upon inactivation of the cmeB gene, from 2 to 4 mg ml 21 , although PAbN reversed this resistance to a CPC MIC of 1 mg ml
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. The erythromycin MICs all decreased upon inactivation of the cmeB gene, in comparison with wildtype C. jejuni NCTC 11168. Therefore, neither of the EPIs had any additional effects on erythromycin susceptibility in this cmeB mutant strain.
Inactivation of cmeF reduced the MICs of BC and CHA twofold, and the MICs of CPC fourfold, although this had no effect on ciprofloxacin and SDS susceptibility, in comparison with wild-type C. jejuni NCTC 11168. The two EPIs had either only minimal additional effects (two-and fourfold MIC reductions) or no effect at all on the susceptibilities to these antimicrobials in this cmeF mutant strain. In contrast, cmeF gene inactivation decreased erythromycin susceptibility (fourfold erythromycin MIC increase) in comparison with wild-type C. jejuni NCTC 11168. Both EPIs provoked eightfold erythromycin MIC reductions in this cmeF mutant. Similar situations were seen for triclosan and TSP, with twofold MIC increases in this cmeF mutant. The triclosan MICs were then reduced by both EPIs, and the TSP MICs were reduced by NMP to their initial wild-type values.
The cmeR gene inactivation increased the MICs of triclosan, TSP and SDS twofold, and the erythromycin MIC fourfold, whilst it had no effect on CPC susceptibility. In contrast, cmeR gene inactivation reduced the BC MIC fourfold, and the MICs of CHA and ciprofloxacin twofold. Both EPIs had only minimal additional effects (twofold MIC reductions) or no effect at all on susceptibilities to all of these antimicrobials in this cmeR mutant strain, with the one exception of PAbN, which provoked an eightfold reduction in the erythromycin MIC.
These findings confirm that efflux has an important role in the resistance of Campylobacter species to a broad range of antimicrobials. The decreases in the biocide resistances with these cmeB and cmeF mutations, the additional effect of both EPIs and the increases in the biocide resistances following cmeR inactivation all suggest that at least two of the efflux systems, CmeABC and CmeDEF, are involved in this biocide resistance. The CmeABC efflux pump has a predominant role in erythromycin resistance, which was demonstrated here by the overall MIC reductions in the cmeB mutant, as well as the MIC increases in the cmeR mutant. These observations are also in agreement with previously published data (Lin et al., 2005; Payot et al., 2004) . This cmeB gene inactivation had unexpected effects on CPC and erythromycin resistances, together with the effects of the cmeF gene inactivation on triclosan and TSP resistances (MICs increased instead of reduced). Moreover, cmeR gene inactivation reduced the BC, CHA and ciprofloxacin resistances. This unexpected turnabout indicates that the exclusion of one of these efflux systems can increase the function of the second, or even of another mechanism of resistance. This coincides with a previous finding on the interactive involvement of the CmeABC and CmeDEF efflux pumps in the extrusion of toxic compounds in C. jejuni, where inactivation of cmeDEF led to increased expression of cmeABC, whereby CmeDEF might be primarily responsive to certain conditions (Akiba et al., 2005) .
We have shown here that active efflux mechanisms have a distinct role in susceptibility to biocides from diverse classes, which might also be related to their different mechanisms of action. In spite of their diverse activities, CHA, CPC and TSP disrupt the same target, the cell membrane. The resistance to these biocides might also be due to membrane structure alterations, as has been observed previously (Tattawasart et al., 2000; Yuk & Marshall, 2006) . In summary, active efflux mechanisms have important roles in the susceptibilities to this broad range of antimicrobials in C. jejuni and C. coli. Both of the putative EPIs, PAbN and NMP, could partially reverse the resistance to all of these antimicrobials. Different PAbN and NMP target preferences were also seen here, with similar situations reported previously (Hannula & Hänninen, 2008; Kern et al., 2006; Pannek et al., 2006) . This might be related to distinct mechanisms of these EPIs in their inhibition of these efflux systems, which are not clearly understood. Potentially, different binding sites of these EPIs on the efflux pumps can interfere with their activities in different ways. Another explanation is that PAbN and NMP have different activities towards the different efflux pumps, which was demonstrated here through comparisons of the effects of these EPIs using mutants lacking the functional genes encoding the CmeB and CmeF efflux pump proteins and CmeR transcriptional repressor. PAbN was less effective in reversing the susceptibilities to triclosan, CPC, CHA, SDS, erythromycin and ciprofloxacin in C. jejuni than in C. coli. This finding can explain the lower occurrence of antimicrobial resistance among C. jejuni compared with C. coli (Avrain et al., 2003; Mavri et al., 2012) . The data presented here also demonstrate that the CmeABC pump has a predominant role in erythromycin resistance in Campylobacter species. In contrast, however, the CmeABC efflux pump appears not to have a predominant role in biocide resistance, with other nonCmeABC efflux systems, like the CmeDEF efflux pump, involved in extrusion of these biocides. Indeed, the exclusion of one of these efflux systems can lead to increased activity of another efflux system, or even the activation of other resistance mechanisms.
All of these findings provide further support for the importance of the involvement of these efflux mechanisms in Campylobacter species antimicrobial resistance. Active efflux is thus a common mechanism of resistance to a range of such chemical agents, and appears to be largely responsible for development of the multidrug resistance phenotype in Campylobacter.
